{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:10:06Z","timestamp":1791443406040,"version":"4.3.3"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T00:00:00Z","timestamp":1281398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T00:00:00Z","timestamp":1281398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1038\/nrgastro.2010.116","type":"journal-article","created":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T04:53:51Z","timestamp":1281416031000},"page":"515-525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":243,"title":["Mechanisms, diagnosis and management of hepatic encephalopathy"],"prefix":"10.1038","volume":"7","author":[{"given":"Ravi","family":"Prakash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,10]]},"reference":[{"key":"BFnrgastro2010116_CR1","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1053\/jhep.2002.31250","volume":"35","author":"P Ferenci","year":"2002","unstructured":"Ferenci, P.  et al. Hepatic encephalopathy\u2014definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35, 716\u2013721 (2002).","journal-title":"Hepatology"},{"key":"BFnrgastro2010116_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11011-006-9042-1","volume":"22","author":"DL Shawcross","year":"2007","unstructured":"Shawcross, D. L., Wright, G., Olde Damink, S. W. & Jalan, R. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab. Brain Dis. 22, 125\u2013138 (2007).","journal-title":"Metab. Brain Dis."},{"key":"BFnrgastro2010116_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jhep.2003.10.016","volume":"40","author":"DL Shawcross","year":"2004","unstructured":"Shawcross, D. L., Davies, N. A., Williams, R. & Jalan, R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J. Hepatol. 40, 247\u2013254 (2004).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2010116_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11011-007-9062-5","volume":"22","author":"MD Norenberg","year":"2007","unstructured":"Norenberg, M. D., Jayakumar, A. R., Rama Rao, K. V. & Panickar, K. S. New concepts in the mechanism of ammonia-induced astrocyte swelling. Metab. Brain Dis. 22, 219\u2013234 (2007).","journal-title":"Metab. Brain Dis."},{"key":"BFnrgastro2010116_CR5","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1515\/BC.2006.171","volume":"387","author":"F Schliess","year":"2006","unstructured":"Schliess, F., G\u00f6rg, B. & H\u00e4ussinger, D. Pathogenetic interplay between osmotic and oxidative stress: the hepatic encephalopathy paradigm. Biol. Chem. 387, 1363\u20131370 (2006).","journal-title":"Biol. Chem."},{"key":"BFnrgastro2010116_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11011-007-9065-2","volume":"22","author":"S Ahboucha","year":"2007","unstructured":"Ahboucha, S. & Butterworth, R. F. The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy. Metab. Brain Dis. 22, 291\u2013308 (2007).","journal-title":"Metab. Brain Dis."},{"key":"BFnrgastro2010116_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/hep.21617","volume":"45","author":"AM Qadri","year":"2007","unstructured":"Qadri, A. M., Ogunwale, B. O. & Mullen, K. D. Can we ignore minimal hepatic encephalopathy any longer? Hepatology 45, 547\u2013548 (2007).","journal-title":"Hepatology"},{"key":"BFnrgastro2010116_CR8","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.4065\/80.11.1501","volume":"80","author":"JA Talwalkar","year":"2005","unstructured":"Talwalkar, J. A. & Kamath, P. S. Influence of recent advances in medical management on clinical outcomes of cirrhosis. Mayo Clin. Proc. 80, 1501\u20131508 (2005).","journal-title":"Mayo Clin. Proc."},{"issue":"Suppl. 1","key":"BFnrgastro2010116_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1746-6342.2006.03215.x","volume":"25","author":"FF Poordad","year":"2007","unstructured":"Poordad, F. F. Review article: the burden of hepatic encephalopathy. Aliment. Pharmacol. Ther. 25 (Suppl. 1), 3\u20139 (2007).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2010116_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/hep.510280108","volume":"28","author":"M Groeneweg","year":"1998","unstructured":"Groeneweg, M.  et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 28, 45\u201349 (1998).","journal-title":"Hepatology"},{"key":"BFnrgastro2010116_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/hep.21533","volume":"45","author":"S Prasad","year":"2007","unstructured":"Prasad, S.  et al. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 45, 549\u2013559 (2007).","journal-title":"Hepatology"},{"key":"BFnrgastro2010116_CR12","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/hep.22032","volume":"47","author":"JS Bajaj","year":"2008","unstructured":"Bajaj, J. S.  et al. Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology 47, 596\u2013604 (2008).","journal-title":"Hepatology"},{"key":"BFnrgastro2010116_CR13","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.cgh.2008.05.025","volume":"6","author":"JS Bajaj","year":"2008","unstructured":"Bajaj, J. S., Saeian, K., Hafeezullah, M., Hoffmann, R. G. & Hammeke, T. A. Patients with minimal hepatic encephalopathy have poor insight into their driving skills. Clin. Gastroenterol. Hepatol. 6, 1135\u20131139 (2008).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2010116_CR14","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/ajg.2009.7","volume":"104","author":"JS Bajaj","year":"2009","unstructured":"Bajaj, J. S.  et al. The effect of fatigue on driving skills in patients with hepatic encephalopathy. Am. J. Gastroenterol. 104, 898\u2013905 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2010116_CR15","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1053\/j.gastro.2009.08.003","volume":"137","author":"G Kircheis","year":"2009","unstructured":"Kircheis, G.  et al. Hepatic encephalopathy and fitness to drive. Gastroenterology 137, 1706\u20131715.e9 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2010116_CR16","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/hep.23128","volume":"50","author":"JS Bajaj","year":"2009","unstructured":"Bajaj, J. S.  et al. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology 50, 1175\u20131183 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro2010116_CR17","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0168-8278(99)80144-5","volume":"30","author":"J Bustamante","year":"1999","unstructured":"Bustamante, J.  et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J. Hepatol. 30, 890\u2013895 (1999).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2010116_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/BF00999607","volume":"2","author":"L Zieve","year":"1987","unstructured":"Zieve, L. Pathogenesis of hepatic encephalopathy. Metab. Brain Dis. 2, 147\u2013165 (1987).","journal-title":"Metab. Brain Dis."},{"key":"BFnrgastro2010116_CR19","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1152\/physrev.1987.67.2.440","volume":"67","author":"AJ Cooper","year":"1987","unstructured":"Cooper, A. J. & Plum, F. Biochemistry and physiology of brain ammonia. Physiol. Rev. 67, 440\u2013519 (1987).","journal-title":"Physiol. Rev."},{"key":"BFnrgastro2010116_CR20","doi-asserted-by":"publisher","first-page":"G373","DOI":"10.1152\/ajpgi.00440.2005","volume":"291","author":"LM Ytreb\u00f8","year":"2006","unstructured":"Ytreb\u00f8, L. M.  et al. Interorgan ammonia, glutamate, and glutamine trafficking in pigs with acute liver failure. Am. J. Physiol. Gastrointest. Liver Physiol. 291, G373\u2013G381 (2006).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro2010116_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11011-008-9122-5","volume":"24","author":"SW Olde Damink","year":"2009","unstructured":"Olde Damink, S. W., Jalan, R. & Dejong, C. H. Interorgan ammonia trafficking in liver disease. Metab. Brain Dis. 24, 169\u2013181 (2009).","journal-title":"Metab. Brain Dis."},{"key":"BFnrgastro2010116_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/BF01995065","volume":"32","author":"M Hahn","year":"1893","unstructured":"Hahn, M., Massen, O., Nencki, M. & Pavlov, I. Die Eck'sche fistel zwischen der unteren hohlvene under pfortader und ihre folgen fur den organismus [German]. Arch. Exp. Pathol. Pharm. 32, 161\u2013210 (1893).","journal-title":"Arch. Exp. Pathol. Pharm."},{"key":"BFnrgastro2010116_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11011-005-7205-0","volume":"20","author":"DL Shawcross","year":"2005","unstructured":"Shawcross, D. L., Olde Damink, S. W., Butterworth, R. F. & Jalan, R. Ammonia and hepatic encephalopathy: the more things change, the more they remain the same. Metab. Brain Dis. 20, 169\u2013179 (2005).","journal-title":"Metab. Brain Dis."},{"key":"BFnrgastro2010116_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1056\/NEJM195208142470703","volume":"247","author":"G Phillips","year":"1952","unstructured":"Phillips, G., Schwartz, R., Gabuzda, G. & Davidson, C. The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances. N. Engl. J. Med. 247, 239\u2013246 (1952).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2010116_CR25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/jcbfm.1991.67","volume":"11","author":"AH Lockwood","year":"1991","unstructured":"Lockwood, A. H., Yap, E. W. & Wong, W. H. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J. Cereb. Blood Flow Metab. 11, 337\u2013341 (1991).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"BFnrgastro2010116_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF01001011","volume":"3","author":"JW Thomas","year":"1988","unstructured":"Thomas, J. W., Banner, C., Whitman, J., Mullen, K. D. & Freese, E. Changes in glutamate-cycle enzyme mRNA levels in a rat model of hepatic encephalopathy. Metab. Brain Dis. 3, 81\u201390 (1988).","journal-title":"Metab. Brain Dis."},{"key":"BFnrgastro2010116_CR27","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/S0168-8278(00)80110-5","volume":"32","author":"D H\u00e4ussinger","year":"2000","unstructured":"H\u00e4ussinger, D., Kircheis, G., Fischer, R., Schiliess, F. & vom Dahl, S. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J. Hepatol. 32, 1035\u20131038 (2000).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2010116_CR28","doi-asserted-by":"publisher","first-page":"4982","DOI":"10.1016\/S0021-9258(18)50550-0","volume":"254","author":"AJ Cooper","year":"1979","unstructured":"Cooper, A. J., McDonald, J. M., Gelbard, A. S., Gledhill, R. F. & Duffy, T. E. The metabolic fate of 13N-labeled ammonia in rat brain. J. Biol. Chem. 254, 4982\u20134992 (1979).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro2010116_CR29","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1136\/gut.2007.122176","volume":"57","author":"D H\u00e4ussinger","year":"2008","unstructured":"H\u00e4ussinger, D. & Schliess, F. Pathogenetic mechanisms of hepatic encephalopathy. Gut 57, 1156\u20131165 (2008).","journal-title":"Gut"},{"key":"BFnrgastro2010116_CR30","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.neuroscience.2004.10.045","volume":"131","author":"H Tanigami","year":"2005","unstructured":"Tanigami, H.  et al. Effect of glutamine synthetase inhibition on astrocyte swelling and altered astroglial protein expression during hyperammonemia in rats. Neuroscience 131, 437\u2013449 (2005).","journal-title":"Neuroscience"},{"key":"BFnrgastro2010116_CR31","doi-asserted-by":"publisher","first-page":"20937","DOI":"10.1074\/jbc.M412448200","volume":"280","author":"C Rose","year":"2005","unstructured":"Rose, C., Kresse, W. & Kettenmann, H. Acute insult of ammonia leads to calcium-dependent glutamate release from cultured astrocytes, an effect of pH. J. Biol. Chem. 280, 20937\u201320944 (2005).","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 1","key":"BFnrgastro2010116_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1471-4159.2006.03796.x","volume":"97","author":"C Rose","year":"2006","unstructured":"Rose, C. Effect of ammonia on astrocytic glutamate uptake\/release mechanisms. J. Neurochem. 97 (Suppl. 1), 11\u201315 (2006).","journal-title":"J. Neurochem."},{"key":"BFnrgastro2010116_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/BF02833602","volume":"6","author":"L Hertz","year":"1987","unstructured":"Hertz, L., Murthy, C. R., Lai, J. C., Fitzpatrick, S. M. & Cooper, A. J. Some metabolic effects of ammonia on astrocytes and neurons in primary cultures. Neurochem. Pathol. 6, 97\u2013129 (1987).","journal-title":"Neurochem. Pathol."},{"key":"BFnrgastro2010116_CR34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1023\/A:1021926405944","volume":"17","author":"J C\u00f3rdoba","year":"2002","unstructured":"C\u00f3rdoba, J., Sanpedro, F., Alonso, J. & Rovira, A. 1H magnetic resonance in the study of hepatic encephalopathy in humans. Metab. Brain Dis. 17, 415\u2013429 (2002).","journal-title":"Metab. Brain Dis."},{"key":"BFnrgastro2010116_CR35","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/hep.21235","volume":"43","author":"D H\u00e4ussinger","year":"2006","unstructured":"H\u00e4ussinger, D. Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 43, 1187\u20131190 (2006).","journal-title":"Hepatology"},{"key":"BFnrgastro2010116_CR36","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3174\/ajnr.A1139","volume":"29","author":"A Rovira","year":"2008","unstructured":"Rovira, A., Alonso, J. & C\u00f3rdoba, J. MR imaging findings in hepatic encephalopathy. AJNR Am. J. Neuroradiol. 29, 1612\u20131621 (2008).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"BFnrgastro2010116_CR37","doi-asserted-by":"publisher","first-page":"G503","DOI":"10.1152\/ajpgi.00104.2004","volume":"287","author":"DL Shawcross","year":"2004","unstructured":"Shawcross, D. L.  et al. Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G503\u2013G509 (2004).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro2010116_CR38","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.1111\/j.1872-034X.2008.00436.x","volume":"38","author":"RF Butterworth","year":"2008","unstructured":"Butterworth, R. F. Pathophysiology of hepatic encephalopathy: The concept of synergism. Hepatol. Res. 38, S116\u2013S121 (2008).","journal-title":"Hepatol. Res."},{"key":"BFnrgastro2010116_CR39","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/00005072-198507000-00004","volume":"44","author":"JB Gregorios","year":"1985","unstructured":"Gregorios, J. B., Mozes, L. W. & Norenberg, M. D. Morphologic effects of ammonia on primary astrocyte cultures. II. Electron microscopic studies. J. Neuropathol. Exp. Neurol. 44, 404\u2013414 (1985).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrgastro2010116_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/BF02833599","volume":"6","author":"MD Norenberg","year":"1987","unstructured":"Norenberg, M. D. The role of astrocytes in hepatic encephalopathy. Neurochem. Pathol. 6, 13\u201333 (1987).","journal-title":"Neurochem. Pathol."},{"key":"BFnrgastro2010116_CR41","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1007\/s00018-005-5089-0","volume":"62","author":"D Shawcross","year":"2005","unstructured":"Shawcross, D. & Jalan, R. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell. Mol. Life Sci. 62, 2295\u20132304 (2005).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFnrgastro2010116_CR42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neuint.2005.04.008","volume":"47","author":"D H\u00e4ussinger","year":"2005","unstructured":"H\u00e4ussinger, D. & Schliess, F. Astrocyte swelling and protein tyrosine nitration in hepatic encephalopathy. Neurochem. Int. 47, 64\u201370 (2005).","journal-title":"Neurochem. Int."},{"key":"BFnrgastro2010116_CR43","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1096\/fasebj.3.5.2784116","volume":"3","author":"LL Moldawer","year":"1989","unstructured":"Moldawer, L. L.  et al. Cachectin\/tumor necrosis factor-\u03b1 alters red blood cell kinetics and induces anemia in vivo. FASEB J. 3, 1637\u20131643 (1989).","journal-title":"FASEB J."},{"key":"BFnrgastro2010116_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0165-5728(95)00148-4","volume":"64","author":"HE de Vries","year":"1996","unstructured":"de Vries, H. E.  et al. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol. 64, 37\u201343 (1996).","journal-title":"J. Neuroimmunol."},{"key":"BFnrgastro2010116_CR45","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1046\/j.1471-4159.2003.01829.x","volume":"86","author":"N Didier","year":"2003","unstructured":"Didier, N.  et al. Secretion of interleukin-1\u03b2 by astrocytes mediates endothelin-1 and tumour necrosis factor-\u03b1 effects on human brain microvascular endothelial cell permeability. J. Neurochem. 86, 246\u2013254 (2003).","journal-title":"J. Neurochem."},{"key":"BFnrgastro2010116_CR46","first-page":"474","volume":"44","author":"A Duchini","year":"1996","unstructured":"Duchini, A. Effects of tumor necrosis factor-\u03b1 and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells. J. Investig. Med. 44, 474\u2013482 (1996).","journal-title":"J. Investig. Med."},{"key":"BFnrgastro2010116_CR47","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1136\/gut.2005.075051","volume":"55","author":"A Cagnin","year":"2006","unstructured":"Cagnin, A., Taylor-Robinson, S. D., Forton, D. M. & Banati, R. B. In vivo imaging of cerebral \u201cperipheral benzodiazepine binding sites\u201d in patients with hepatic encephalopathy. Gut 55, 547\u2013553 (2006).","journal-title":"Gut"},{"key":"BFnrgastro2010116_CR48","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.neuint.2007.05.004","volume":"52","author":"S Ahboucha","year":"2008","unstructured":"Ahboucha, S. & Butterworth, R. F. The neurosteroid system: implication in the pathophysiology of hepatic encephalopathy. Neurochem. Int. 52, 575\u2013587 (2008).","journal-title":"Neurochem. Int."},{"key":"BFnrgastro2010116_CR49","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S0306-4530(98)00071-7","volume":"23","author":"EE Baulieu","year":"1998","unstructured":"Baulieu, E. E. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23, 963\u2013987 (1998).","journal-title":"Psychoneuroendocrinology"},{"key":"BFnrgastro2010116_CR50","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.tips.2006.06.005","volume":"27","author":"V Papadopoulos","year":"2006","unstructured":"Papadopoulos, V.  et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 27, 402\u2013409 (2006).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnrgastro2010116_CR51","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.neuroscience.2005.05.063","volume":"138","author":"V Papadopoulos","year":"2006","unstructured":"Papadopoulos, V., Lecanu, L., Brown, R. C., Han, Z. & Yao, Z. X. Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience 138, 749\u2013756 (2006).","journal-title":"Neuroscience"},{"key":"BFnrgastro2010116_CR52","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0197-0186(02)00031-1","volume":"41","author":"P Desjardins","year":"2002","unstructured":"Desjardins, P. & Butterworth, R. F. The \u201cperipheral-type\u201d benzodiazepine (omega 3) receptor in hyperammonemic disorders. Neurochem. Int. 41, 109\u2013114 (2002).","journal-title":"Neurochem. Int."},{"key":"BFnrgastro2010116_CR53","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jhep.2004.12.029","volume":"42","author":"M B\u00e9langer","year":"2005","unstructured":"B\u00e9langer, M., Desjardins, P., Chatauret, N., Rose, C. & Butterworth, R. F. Mild hypothermia prevents brain edema and attenuates up-regulation of the astrocytic benzodiazepine receptor in experimental acute liver failure. J. Hepatol. 42, 694\u2013699 (2005).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2010116_CR54","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.neuint.2005.12.006","volume":"48","author":"S Ahboucha","year":"2006","unstructured":"Ahboucha, S., Coyne, L., Hirakawa, R., Butterworth, R. F. & Halliwell, R. F. An interaction between benzodiazepines and neuroactive steroids at GABAA receptors in cultured hippocampal neurons. Neurochem. Int. 48, 703\u2013707 (2006).","journal-title":"Neurochem. Int."},{"key":"BFnrgastro2010116_CR55","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/jnr.1222","volume":"66","author":"CR Murthy","year":"2001","unstructured":"Murthy, C. R., Rama Rao, K. V., Bai, G. & Norenberg, M. D. Ammonia-induced production of free radicals in primary cultures of rat astrocytes. J. Neurosci. Res. 66, 282\u2013298 (2001).","journal-title":"J. Neurosci. Res."},{"key":"BFnrgastro2010116_CR56","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/hep.510310322","volume":"31","author":"C Hermenegildo","year":"2000","unstructured":"Hermenegildo, C., Monfort, P. & Felipo, V. Activation of N-methyl-D-aspartate receptors in rat brain in vivo following acute ammonia intoxication: characterization by in vivo brain microdialysis. Hepatology 31, 709\u2013715 (2000).","journal-title":"Hepatology"},{"key":"BFnrgastro2010116_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0014-2999(03)01667-4","volume":"468","author":"W Hilgier","year":"2003","unstructured":"Hilgier, W., Anderzhanova, E., Oja, S. S., Saransaari, P. & Albrecht, J. Taurine reduces ammonia- and N-methyl-D-aspartate-induced accumulation of cyclic GMP and hydroxyl radicals in microdialysates of the rat striatum. Eur. J. Pharmacol. 468, 21\u201325 (2003).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnrgastro2010116_CR58","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/glia.20504","volume":"55","author":"R Reinehr","year":"2007","unstructured":"Reinehr, R.  et al. Hypoosmotic swelling and ammonia increase oxidative stress by NADPH oxidase in cultured astrocytes and vital brain slices. Glia 55, 758\u2013771 (2007).","journal-title":"Glia"},{"key":"BFnrgastro2010116_CR59","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/hep.21357","volume":"44","author":"J Albrecht","year":"2006","unstructured":"Albrecht, J. & Norenberg, M. D. Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology 44, 788\u2013794 (2006).","journal-title":"Hepatology"},{"key":"BFnrgastro2010116_CR60","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1096\/fj.01-0862fje","volume":"16","author":"F Schliess","year":"2002","unstructured":"Schliess, F.  et al. Ammonia induces MK-801-sensitive nitration and phosphorylation of protein tyrosine residues in rat astrocytes. FASEB J. 16, 739\u2013741 (2002).","journal-title":"FASEB J."},{"key":"BFnrgastro2010116_CR61","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1055\/s-2007-1007238","volume":"16","author":"KD Mullen","year":"1996","unstructured":"Mullen, K. D. & Jones, E. A. Natural benzodiazepines and hepatic encephalopathy. Semin. Liver Dis. 16, 255\u2013264 (1996).","journal-title":"Semin. Liver Dis."},{"key":"BFnrgastro2010116_CR62","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1053\/gast.1996.v111.agast961110256","volume":"111","author":"KD Mullen","year":"1996","unstructured":"Mullen, K. D., Cole, M. & Foley, J. M. Neurological deficits in \u201cawake\u201d cirrhotic patients on hepatic encephalopathy treatment: missed metabolic or metal disorder? Gastroenterology 111, 256\u2013257 (1996).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2010116_CR63","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/S0016-5085(99)70457-9","volume":"117","author":"C Rose","year":"1999","unstructured":"Rose, C.  et al. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 117, 640\u2013644 (1999).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2010116_CR64","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1148\/radiology.216.3.r00se27683","volume":"216","author":"T Naegele","year":"2000","unstructured":"Naegele, T.  et al. MR imaging and 1H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation. Radiology 216, 683\u2013691 (2000).","journal-title":"Radiology"},{"key":"BFnrgastro2010116_CR65","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1002\/mds.21096","volume":"21","author":"A Aggarwal","year":"2006","unstructured":"Aggarwal, A.  et al. Reversible Parkinsonism and T1W pallidal hyperintensities in acute liver failure. Mov. Disord. 21, 1986\u20131990 (2006).","journal-title":"Mov. Disord."},{"key":"BFnrgastro2010116_CR66","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S0140-6736(95)92164-8","volume":"346","author":"D Krieger","year":"1995","unstructured":"Krieger, D.  et al. Manganese and chronic hepatic encephalopathy. Lancet 346, 270\u2013274 (1995).","journal-title":"Lancet"},{"key":"BFnrgastro2010116_CR67","first-page":"528","volume":"82","author":"H Tsuji","year":"1991","unstructured":"Tsuji, H.  et al. A case of liver cirrhosis associated with chronic subdural hematoma and hepatic encephalopathy [Japanese]. Fukuoka Igaku Zasshi. 82, 528\u2013532 (1991).","journal-title":"Fukuoka Igaku Zasshi."},{"key":"BFnrgastro2010116_CR68","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1378\/chest.124.3.1016","volume":"124","author":"MG Foreman","year":"2003","unstructured":"Foreman, M. G., Mannino, D. M. & Moss, M. Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest 124, 1016\u20131020 (2003).","journal-title":"Chest"},{"key":"BFnrgastro2010116_CR69","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0016-5085(77)80135-2","volume":"72","author":"HO Conn","year":"1977","unstructured":"Conn, H. O.  et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 72, 573\u2013583 (1977).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2010116_CR70","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1002\/hep.23216","volume":"50","author":"JS Bajaj","year":"2009","unstructured":"Bajaj, J. S., Wade, J. B. & Sanyal, A. J. Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy. Hepatology 50, 2014\u20132021 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro2010116_CR71","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0140-6736(57)90005-3","volume":"273","author":"BG Parsons-Smith","year":"1957","unstructured":"Parsons-Smith, B. G., Summerskill, W. H., Dawson, A. M. & Sherlock, S. The electroencephalograph in liver disease. Lancet 273, 867\u2013871 (1957).","journal-title":"Lancet"},{"key":"BFnrgastro2010116_CR72","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(76)92215-7","volume":"15","author":"B Jennett","year":"1976","unstructured":"Jennett, B., Teasdale, G., Braakman, R., Minderhoud, J. & Knill-Jones, R. Predicting outcome in individual patients after severe head injury. Lancet 15, 1031\u20131034 (1976).","journal-title":"Lancet"},{"key":"BFnrgastro2010116_CR73","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1023\/B:MEBR.0000043977.11113.2a","volume":"19","author":"S Montagnese","year":"2004","unstructured":"Montagnese, S., Amodio, P. & Morgan, M. Y. Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach. Metab. Brain Dis. 19, 281\u2013312 (2004).","journal-title":"Metab. Brain Dis."},{"key":"BFnrgastro2010116_CR74","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1023\/B:MEBR.0000043975.01841.de","volume":"19","author":"P Amodio","year":"2004","unstructured":"Amodio, P., Montagnese, S., Gatta, A. & Morgan, M. Y. Characteristics of minimal hepatic encephalopathy. Metab. Brain Dis. 19, 253\u2013267 (2004).","journal-title":"Metab. Brain Dis."},{"key":"BFnrgastro2010116_CR75","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10620-007-9895-0","volume":"53","author":"TI Hassanein","year":"2008","unstructured":"Hassanein, T. I., Hilsabeck, R. C. & Perry, W. Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA). Dig. Dis. Sci. 53, 529\u2013538 (2008).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro2010116_CR76","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S0168-8278(01)00026-5","volume":"34","author":"K Weissenborn","year":"2001","unstructured":"Weissenborn, K.  et al. Neuropsychological characterization of hepatic encephalopathy. J. Hepatol. 34, 768\u2013773 (2001).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2010116_CR77","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/j.1478-3231.2009.02009.x","volume":"29","author":"C Randolph","year":"2009","unstructured":"Randolph, C.  et al. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int. 29, 629\u2013635 (2009).","journal-title":"Liver Int."},{"key":"BFnrgastro2010116_CR78","unstructured":"RED Hepatic Encephalopathy [Spanish]. Spanish normative data for hepatic encephalopathy [online], (2010)."},{"key":"BFnrgastro2010116_CR79","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1016\/j.transproceed.2006.10.050","volume":"38","author":"T Meyer","year":"2006","unstructured":"Meyer, T., Eshelman, A. & Abouljoud, M. Neuropsychological changes in a large sample of liver transplant candidates. Transplant. Proc. 38, 3559\u20133560 (2006).","journal-title":"Transplant. Proc."},{"key":"BFnrgastro2010116_CR80","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1440-1819.2006.01483.x","volume":"60","author":"JH Sorrell","year":"2006","unstructured":"Sorrell, J. H., Zolnikov, B. J., Sharma, A. & Jinnai, I. Cognitive impairment in people diagnosed with end-stage liver disease evaluated for liver transplantation. Psychiatry Clin. Neurosci. 60, 174\u2013181 (2006).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"BFnrgastro2010116_CR81","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/j.1572-0241.2007.01048.x","volume":"102","author":"JS Bajaj","year":"2007","unstructured":"Bajaj, J. S.  et al. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am. J. Gastroenterol. 102, 754\u2013760 (2007).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2010116_CR82","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1053\/j.gastro.2008.07.021","volume":"135","author":"JS Bajaj","year":"2008","unstructured":"Bajaj, J. S.  et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology 135, 1591\u20131600 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2010116_CR83","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1053\/j.gastro.2008.06.043","volume":"135","author":"H Mardini","year":"2008","unstructured":"Mardini, H., Saxby, B. K. & Record, C. O. Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant. Gastroenterology 135, 1582\u20131590 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2010116_CR84","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1053\/jhep.2002.30957","volume":"35","author":"G Kircheis","year":"2002","unstructured":"Kircheis, G., Wettstein, M., Timmermann, L., Schnitzler, A. & H\u00e4ussinger, D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 35, 357\u2013366 (2002).","journal-title":"Hepatology"},{"key":"BFnrgastro2010116_CR85","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1097\/MEG.0b013e328310e0c3","volume":"21","author":"G Kircheis","year":"2009","unstructured":"Kircheis, G.  et al. Diagnostic and prognostic values of critical flicker frequency determination as new diagnostic tool for objective HE evaluation in patients undergoing TIPS implantation. Eur. J. Gastroenterol. Hepatol. 21, 1383\u20131394 (2009).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2010116_CR86","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.neucli.2009.02.002","volume":"39","author":"P Amodio","year":"2009","unstructured":"Amodio, P.  et al. Electroencephalographic analysis for the assessment of hepatic encephalopathy: comparison of non-parametric and parametric spectral estimation techniques. Neurophysiol. Clin. 39, 107\u2013115 (2009).","journal-title":"Neurophysiol. Clin."},{"key":"BFnrgastro2010116_CR87","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0002-9343(02)01477-8","volume":"114","author":"JP Ong","year":"2003","unstructured":"Ong, J. P.  et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am. J. Med. 114, 188\u2013193 (2003).","journal-title":"Am. J. Med."},{"key":"BFnrgastro2010116_CR88","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/0168-8278(89)90009-3","volume":"8","author":"MY Morgan","year":"1989","unstructured":"Morgan, M. Y., Alonso, M. & Stanger, L. C. Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study. J. Hepatol. 8, 208\u2013217 (1989).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2010116_CR89","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/hep.1840070617","volume":"7","author":"MY Morgan","year":"1987","unstructured":"Morgan, M. Y. & Hawley, K. E. Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial. Hepatology 7, 1278\u20131284 (1987).","journal-title":"Hepatology"},{"key":"BFnrgastro2010116_CR90","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S0168-8278(87)80086-7","volume":"4","author":"MY Morgan","year":"1987","unstructured":"Morgan, M. Y., Hawley, K. E. & Stambuk, D. Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study. J. Hepatol. 4, 236\u2013244 (1987).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2010116_CR91","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(88)91033-1","volume":"1","author":"PA van Leeuwen","year":"1988","unstructured":"van Leeuwen, P. A., van Berlo, C. L. & Soeters, P. B. New mode of action for lactulose. Lancet 1, 55\u201356 (1988).","journal-title":"Lancet"},{"key":"BFnrgastro2010116_CR92","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1586\/17474124.2.6.785","volume":"2","author":"JS Bajaj","year":"2008","unstructured":"Bajaj, J. S. Management options for minimal hepatic encephalopathy. Expert Rev. Gastroenterol. Hepatol. 2, 785\u2013790 (2008).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"BFnrgastro2010116_CR93","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s11011-007-9061-6","volume":"22","author":"KD Mullen","year":"2007","unstructured":"Mullen, K. D., Amodio, P & Morgan, M. Y. Therapeutic studies in hepatic encephalopathy. Metab. Brain Dis. 22, 407\u2013423 (2007).","journal-title":"Metab. Brain Dis."},{"key":"BFnrgastro2010116_CR94","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","volume":"362","author":"NM Bass","year":"2010","unstructured":"Bass, N. M.  et al. Rifaximin treatment in hepatic encephalopathy. N. Engl. J. Med. 362, 1071\u20131081 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2010116_CR95","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.clnu.2006.01.018","volume":"25","author":"M Plauth","year":"2006","unstructured":"Plauth, M.  et al. ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin. Nutr. 25, 285\u2013294 (2006).","journal-title":"Clin. Nutr."},{"key":"BFnrgastro2010116_CR96","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jhep.2004.05.010","volume":"41","author":"KD Mullen","year":"2004","unstructured":"Mullen, K. D. & Dasarathy, S. Protein restriction in hepatic encephalopathy: necessary evil or illogical dogma? J. Hepatol. 41, 147\u2013148 (2004).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2010116_CR97","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1542-3565(05)00017-0","volume":"3","author":"Y Muto","year":"2005","unstructured":"Muto, Y.  et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin. Gastroenterol. Hepatol. 3, 705\u2013713 (2005).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2010116_CR98","doi-asserted-by":"crossref","unstructured":"Als-Nielsen, B., Koretz, R. L., Kjaergard, L. L. & Gluud, C. Branched-chain amino acids for hepatic encephalopathy. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD001939. doi:10.1002\/14651858.CD001939 (2003).","DOI":"10.1002\/14651858.CD001939"},{"key":"BFnrgastro2010116_CR99","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S1590-8658(01)80028-1","volume":"33","author":"P Amodio","year":"2001","unstructured":"Amodio, P.  et al. Vegetarian diets in hepatic encephalopathy: facts or fantasies? Dig. Liver Dis. 33, 492\u2013500 (2001).","journal-title":"Dig. Liver Dis."},{"key":"BFnrgastro2010116_CR100","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1365-2036.2009.04211.x","volume":"31","author":"JS Bajaj","year":"2010","unstructured":"Bajaj, J. S. Review article: the modern management of hepatic encephalopathy. Aliment. Pharmacol. Ther. 31, 537\u2013547 (2010).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2010116_CR101","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/lt.21129","volume":"13","author":"CA Stewart","year":"2007","unstructured":"Stewart, C. A., Malinchoc, M., Kim, W. R. & Kamath, P. S. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl. 13, 1366\u20131371 (2007).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2010116_CR102","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.2214\/AJR.09.2968","volume":"193","author":"F Fanelli","year":"2009","unstructured":"Fanelli, F.  et al. Management of refractory hepatic encephalopathy after insertion of TIPS: long-term results of shunt reduction with hourglass-shaped balloon-expandable stent-graft. AJR Am. J. Roentgenol. 193, 1696\u20131702 (2009).","journal-title":"AJR Am. J. Roentgenol."},{"key":"BFnrgastro2010116_CR103","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00109-006-0149-y","volume":"85","author":"C Montoliu","year":"2007","unstructured":"Montoliu, C.  et al. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients. J. Mol. Med. 85, 237\u2013245 (2007).","journal-title":"J. Mol. Med."},{"key":"BFnrgastro2010116_CR104","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00109-007-0160-y","volume":"85","author":"J Albrecht","year":"2007","unstructured":"Albrecht, J. Cyclic GMP in blood and minimal hepatic encephalopathy: fine-tuning of the diagnosis. J. Mol. Med. 85, 203\u2013205 (2007).","journal-title":"J. Mol. Med."},{"key":"BFnrgastro2010116_CR105","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/hep.510230523","volume":"23","author":"G Marchesini","year":"1996","unstructured":"Marchesini, G., Fabbri, A., Bianchi, G., Brizi, M. & Zoli, M. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology 23, 1084\u20131092 (1996).","journal-title":"Hepatology"},{"key":"BFnrgastro2010116_CR106","first-page":"414","volume":"2","author":"G Bresci","year":"1993","unstructured":"Bresci, G., Parisi, G. & Banti, S. Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment. Eur. J. Med. 2, 414\u2013416 (1993).","journal-title":"Eur. J. Med."},{"key":"BFnrgastro2010116_CR107","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/0016-5085(80)90665-4","volume":"78","author":"MY Morgan","year":"1980","unstructured":"Morgan, M. Y., Jakobovits, A. W., James, I. M. & Sherlock, S. Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology 78, 663\u2013670 (1980).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2010116_CR108","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/hep.1840160123","volume":"16","author":"S Sushma","year":"1992","unstructured":"Sushma, S.  et al. Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial. Hepatology 16, 138\u2013144 (1992).","journal-title":"Hepatology"},{"key":"BFnrgastro2010116_CR109","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/hep.510250609","volume":"25","author":"G Kircheis","year":"1997","unstructured":"Kircheis, G.  et al. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Hepatology 25, 1351\u20131360 (1997).","journal-title":"Hepatology"},{"key":"BFnrgastro2010116_CR110","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1023\/A:1021934607762","volume":"17","author":"G Kircheis","year":"2002","unstructured":"Kircheis, G., Wettstein, M., Dahl, S. & H\u00e4ussinger, D. Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy. Metab. Brain Dis. 17, 453\u2013462 (2002).","journal-title":"Metab. Brain Dis."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2010.116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2010.116","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2010.116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T09:27:53Z","timestamp":1650014873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2010.116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,10]]},"references-count":110,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["BFnrgastro2010116"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2010.116","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,10]]},"assertion":[{"value":"10 August 2010","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K. D. Mullen is a consultant for Ocera Therapeutics and a consultant and speaker for Salix Pharmaceuticals (he has received honoria, but not for this manuscript). R. Prakash declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}